Rat monoclonal antibodies against bone sialoprotein II inhibit tumor growth and osteolytic lesions in nude rats induced by MDA-MB-231 breast cancer cells

International Journal of Clinical Pharmacology and Therapeutics

Volumn 48, Issue 7, 2010, Pages 462-464

  Zepp, M ^a   Armbruster, F P ^b   Berger, M R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b IMMUNDIAGNOSTIK AG   (Germany)

Author keywords

Antibody therapy; Bone metastasis; Bone sialoprotein II; Breast cancer; Luciferase; MDA MB 231; Xenografts

Indexed keywords

BONE SIALOPROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER REGRESSION; CANCER TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE RAT; OSTEOLYSIS; RAT; TREATMENT DURATION; TUMOR VOLUME;

EID: 77954897960     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP48462     Document Type: Conference Paper

References (7)

1. Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, HERA study team et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. J Lancet. 2007; 369: 29-36. (Pubitemid 46039831)
2. Bellahcne A, Castronovo V, Ogbureke KUL et al. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer J Nature Reviews Cancer. 2008; 8: 212-226.
3. Diel IJ, Solomayer EF, Seibel MJ et al. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis J Clin Cancer Res. 1999; 5: 3914-3919.
4. Adwan H, Bäuerle T, Berger MR. Down-regulation of osteopontin and bone sialoprotein is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. J Cancer Gene Therapy. 2004; 11: 109-120. (Pubitemid 38141773)
5. Adwan H, Bäuerle T, Najajreh Y, Elazer V, Golomb G, Berger MR. Decreased levels of osteopontin and bone sialoprotein are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. J Int J Oncol. 2004; 24: 1235-1244.
6. Bäuerle T, Adwan H, Kiessling F, Hilbig H, Armbruster FP, Berger MR. Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. J Int J Cancer. 2005; 115: 177-186. (Pubitemid 40586725)
7. Bäuerle T, Peterschmitt J, Hilbig H, Kiessling F, Armbruster FP, Berger MR. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein. J Int J Oncol. 2006; 28: 573-583.